// you're reading...

News

European RTD project planed on pancreatic beta-cell imaging in vitro and in vivo

EU-consortium meet in Copenhagen to discuss multiple application of the monoclonal autoantibody IC2 in noninvasive medical imaging by MRI, SPECT, PET and other innovative new methods.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart